Insider Trading & Ownership - Y-mAbs Therapeutics Inc. (YMAB)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Y-mAbs Therapeutics Inc.
Goto Prev, 0, 1, 2, 3, 4, 5, Next
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2023-12-13
Sale		 2023-12-15
7:40 pm		 Y-mAbs Therapeutics Inc. YMAB Gad Thomas
Chief Business Officer		 150,000 $6.6733 $1,001,000 415,532
(Indirect
Direct)		 View
2023-12-11
Purchase		 2023-12-12
08:27 am		 Y-mAbs Therapeutics Inc. YMAB WG Biotech ApS
Director		 6,455 $6.8523 $44,232 4,559,233
(Direct)		 View
2023-12-11
Purchase		 2023-12-12
08:26 am		 Y-mAbs Therapeutics Inc. YMAB Wedell-Wedellsborg Johan
Director		 6,455 $6.8523 $44,232 4,559,233
(Indirect)		 View
2023-12-07
Purchase		 2023-12-11
5:25 pm		 Y-mAbs Therapeutics Inc. YMAB WG Biotech ApS
Director		 127,549 $6.9809 $890,411 4,552,778
(Direct)		 View
2023-12-07
Purchase		 2023-12-11
5:25 pm		 Y-mAbs Therapeutics Inc. YMAB Wedell-Wedellsborg Johan
Director		 127,549 $6.9809 $890,411 4,552,778
(Indirect)		 View
2023-11-29
Purchase		 2023-12-01
5:15 pm		 Y-mAbs Therapeutics Inc. YMAB WG Biotech ApS
Director		 51,837 $5.9702 $309,477 4,425,229
(Direct)		 View
2023-11-29
Purchase		 2023-12-01
5:14 pm		 Y-mAbs Therapeutics Inc. YMAB Wedell-Wedellsborg Johan
Director		 51,837 $5.9702 $309,477 4,425,229
(Indirect)		 View
2023-11-27
Purchase		 2023-11-29
5:15 pm		 Y-mAbs Therapeutics Inc. YMAB Wedell-Wedellsborg Johan
Director		 93,187 $5.5941 $521,294 4,373,392
(Indirect)		 View
2023-11-27
Purchase		 2023-11-29
5:14 pm		 Y-mAbs Therapeutics Inc. YMAB WG Biotech ApS
Director		 93,187 $5.5941 $521,294 4,373,392
(Direct)		 View
2023-11-20
Sale		 2023-11-22
5:00 pm		 Y-mAbs Therapeutics Inc. YMAB Gad Thomas
Chief Business Officer		 150,000 $5.3026 $795,383 565,532
(Indirect
Direct)		 View
2023-05-15
Purchase		 2023-05-17
5:07 pm		 Y-mAbs Therapeutics Inc. YMAB Wedell-Wedellsborg Johan
Director		 101,740 $9.6462 $981,404 4,280,205
(Indirect)		 View
2023-05-15
Purchase		 2023-05-17
5:05 pm		 Y-mAbs Therapeutics Inc. YMAB WG Biotech ApS
See remarks		 101,740 $9.6462 $981,404 4,280,205
(Direct)		 View
2022-11-15
Purchase		 2022-11-16
7:01 pm		 Y-mAbs Therapeutics Inc. YMAB Rajah Vignesh
SVP & CMO		 1,195 $4.924 $5,884 4,266
(Indirect)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2023-11-06
Option Award		 2023-11-08
5:19 pm		 N/A
2033-11-06		 Y-mAbs Therapeutics Inc. YMAB Gad Thomas
Chief Business Officer		 75,000 $0 75,000
(Direct)		 View
2023-11-06
Option Award		 2023-11-08
5:16 pm		 N/A
2033-11-06		 Y-mAbs Therapeutics Inc. YMAB Rossi Michael J
President and CEO		 615,240 $0 615,240
(Direct)		 View
2023-06-08
Option Award		 2023-06-09
6:05 pm		 N/A
2033-06-08		 Y-mAbs Therapeutics Inc. YMAB Hamill Laura
Director		 16,280 $0 16,280
(Direct)		 View
2023-06-08
Option Award		 2023-06-09
6:04 pm		 N/A
2033-06-08		 Y-mAbs Therapeutics Inc. YMAB Wedell-Wedellsborg Johan
Director		 16,280 $0 4,296,485
(Direct)		 View
2023-06-08
Option Award		 2023-06-09
6:02 pm		 N/A
2033-06-08		 Y-mAbs Therapeutics Inc. YMAB Ber Gerard
Director		 16,280 $0 16,280
(Direct)		 View
2023-06-08
Option Award		 2023-06-09
6:01 pm		 N/A
2033-06-08		 Y-mAbs Therapeutics Inc. YMAB GILL DAVID N
Director		 16,280 $0 16,280
(Direct)		 View
2023-06-08
Option Award		 2023-06-09
6:00 pm		 N/A
2033-06-08		 Y-mAbs Therapeutics Inc. YMAB HEALY JAMES
Director		 16,280 $0 2,236,336
(Direct)		 View
2023-06-08
Option Award		 2023-06-09
6:00 pm		 N/A
2033-06-08		 Y-mAbs Therapeutics Inc. YMAB TYAGI ASHU
Director		 16,280 $0 16,280
(Direct)		 View
2023-01-26
Option Award		 2023-01-30
4:35 pm		 N/A
2033-01-26		 Y-mAbs Therapeutics Inc. YMAB Lisby Steen
SVP & CHIEF SCIENTIFIC OFFICER		 32,000 $0 32,000
(Direct)		 View
2023-01-26
Option Award		 2023-01-30
4:34 pm		 N/A
2033-01-26		 Y-mAbs Therapeutics Inc. YMAB Lund-Hansen Torben
SVP & CHIEF TECHNICAL OFFICER		 32,000 $0 32,000
(Direct)		 View
2023-01-26
Option Award		 2023-01-30
4:33 pm		 N/A
2033-01-26		 Y-mAbs Therapeutics Inc. YMAB Rajah Vignesh
SVP & CHIEF MEDICAL OFFICER		 32,000 $0 32,000
(Direct)		 View
2023-01-26
Option Award		 2023-01-30
4:32 pm		 N/A
2033-01-26		 Y-mAbs Therapeutics Inc. YMAB Smith Susan Laura
SVP & CHIEF COMMERCIAL OFFICER		 32,000 $0 32,000
(Direct)		 View
2023-01-26
Option Award		 2023-01-30
4:31 pm		 N/A
2033-01-26		 Y-mAbs Therapeutics Inc. YMAB Wilms Joris
SVP & CHIEF OPERATING OFFICER		 32,000 $0 32,000
(Direct)		 View
2023-01-17
Option Award		 2023-01-19
4:45 pm		 N/A
2033-01-17		 Y-mAbs Therapeutics Inc. YMAB Rajah Vignesh
SVP & CHIEF MEDICAL OFFICER		 53,500 $0 57,766
(Direct)		 View
2023-01-17
Option Award		 2023-01-19
4:44 pm		 N/A
2033-01-17		 Y-mAbs Therapeutics Inc. YMAB Lund-Hansen Torben
SVP & CHIEF TECHNICAL OFFICER		 53,500 $0 99,162
(Direct)		 View
2023-01-17
Option Award		 2023-01-19
4:42 pm		 N/A
2033-01-17		 Y-mAbs Therapeutics Inc. YMAB Gad Thomas
See remarks		 283,700 $0 958,732
(Direct)		 View
2023-01-17
Option Award		 2023-01-19
4:40 pm		 N/A
2033-01-17		 Y-mAbs Therapeutics Inc. YMAB Smith Susan Laura
SVP & CHIEF COMMERCIAL OFFICER		 53,500 $0 53,500
(Direct)		 View
2023-01-17
Option Award		 2023-01-19
4:39 pm		 N/A
2033-01-17		 Y-mAbs Therapeutics Inc. YMAB Lisby Steen
SVP & CHIEF SCIENTIFIC OFFICER		 53,500 $0 53,500
(Direct)		 View
2023-01-17
Option Award		 2023-01-19
4:36 pm		 N/A
2033-01-17		 Y-mAbs Therapeutics Inc. YMAB Wilms Joris
SVP & CHIEF OPERATING OFFICER		 53,500 $0 53,500
(Direct)		 View
2023-01-17
Option Award		 2023-01-19
4:34 pm		 N/A
2033-01-17		 Y-mAbs Therapeutics Inc. YMAB Kruse Bo
EVP, CFO, Secry & Treas.		 81,800 $0 262,877
(Direct)		 View
2022-07-15
Option Award		 2022-07-19
1:24 pm		 N/A
2032-07-14		 Y-mAbs Therapeutics Inc. YMAB Hamill Laura
Director		 16,000 $0 16,000
(Direct)		 View
2022-07-15
Option Award		 2022-07-19
1:23 pm		 N/A
2032-07-14		 Y-mAbs Therapeutics Inc. YMAB Wedell-Wedellsborg Johan
Director		 16,000 $0 16,000
(Direct)		 View
2022-07-15
Option Award		 2022-07-19
1:22 pm		 N/A
2032-07-14		 Y-mAbs Therapeutics Inc. YMAB HEALY JAMES
Director		 16,000 $0 16,000
(Direct)		 View
2022-07-15
Option Award		 2022-07-19
1:21 pm		 N/A
2032-07-14		 Y-mAbs Therapeutics Inc. YMAB Ber Gerard
Director		 16,000 $0 16,000
(Direct)		 View
2022-07-15
Option Award		 2022-07-19
1:20 pm		 N/A
2032-07-14		 Y-mAbs Therapeutics Inc. YMAB GILL DAVID N
Director		 16,000 $0 16,000
(Direct)		 View
2022-07-15
Option Award		 2022-07-19
1:18 pm		 N/A
2032-07-14		 Y-mAbs Therapeutics Inc. YMAB TYAGI ASHU
Director		 16,000 $0 16,000
(Direct)		 View
Goto Prev, 0, 1, 2, 3, 4, 5, Next